What's new in DyslipidemiaLast update of the site: Tuesday August 02, 2022
de Sá João Roberto et al. | Diabetology & Metabolic Syndrome 2022;...
Diabetic kidney disease is the leading cause of entry into renal replacement therapy and is associated...
Belanger, Matthew J.MD et al. | Cardiology in Review 2022; 30(4): 206-13...
Advances in genotyping technologies, bioinformatics tools, and analytical approaches have made it possible...
Kwon Oh Chan et al. | Arthritis Research & Therapy 2022; 24(1):...
Axial spondyloarthritis (axSpA) is a chronic inflammatory arthritis that mainly affects the axial skeleton...
Hiroaki
Yagyu
et al. | Journal of Diabetes Investigation 2022;...
The International Diabetes Federation reported that there were 424.9 million people with diabetes...
Szili-Torok Tamas et al. | Cardiovascular Diabetology 2022; 21(1):...
Type 2 diabetes is a common disease with worldwide rising incidence and prevalence [1]. Affected patients...
Steenhuis Dennis et al. | Cardiovascular therapeutics 2022 (2022),...
In 2019, approximately two million (12%) Dutch inhabitants were on lipid-lowering therapies, with the...
Young Tamara K. et al. | Journal of diabetes research 2022 (2022),...
Minimal trauma fractures are a global health issue, with an annual toll of 9 million fractures, 740,000...
Brandon K.
Bellows
PharmD et al. | Journal of the American Heart Association...
Individual clinical and genotype data from the UK Biobank were used to estimate the probability of any...
Lisandro D. Colantonio MD et al. | Journal of the American Heart Association...
Black and White US adults with a history of atherosclerotic cardiovascular disease who had higher lipoprotein(a)...
Bibliographical searchFocus and target to your research of scientific data
Research by journal
824 articles currently available
Search By Subject
Top articlesThe 5 most read articles
Steenhuis Dennis et al. | Cardiovascular therapeutics 2022 (2022),...
In 2019, approximately two million (12%) Dutch inhabitants were on lipid-lowering therapies, with the vast majority on 3-hydroxy-3-methylglutaryl-coe nzyme A (HMG-CoA) reductase inhibitors or statins (97%)...
de Sá João Roberto et al. | Diabetology & Metabolic Syndrome 2022;...
Diabetic kidney disease is the leading cause of entry into renal replacement therapy and is associated with increased morbidity and mortality [1, 2].
In 2007, the Kidney Disease Outcomes Quality Initiative...
Belanger, Matthew J.MD et al. | Cardiology in Review 2022; 30(4): 206-13...
Advances in genotyping technologies, bioinformatics tools, and analytical approaches have made it possible to obtain genetic testing for specific cardiovascular (CV) diseases from a Clinical Laboratory...
Young Tamara K. et al. | Journal of diabetes research 2022 (2022),...
Minimal trauma fractures are a global health issue, with an annual toll of 9 million fractures, 740,000 associated-deaths, and accounting for a loss of 1.75 million disability-adjusted life-years [1]....
Lisandro D. Colantonio MD et al. | Journal of the American Heart Association...
Black and White US adults with a history of atherosclerotic cardiovascular disease who had higher lipoprotein(a) levels had an increased risk for future coronary heart disease events.
The association...